327 related articles for article (PubMed ID: 34213838)
1. Engineering Tools for Regulating Hypoxia in Tumour Models.
Kim MH; Green SD; Lin CC; Konig H
J Cell Mol Med; 2021 Aug; 25(16):7581-7592. PubMed ID: 34213838
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells.
Govaert KM; Emmink BL; Nijkamp MW; Cheung ZJ; Steller EJ; Fatrai S; de Bruijn MT; Kranenburg O; Borel Rinkes IH
Ann Surg; 2014 Apr; 259(4):750-9. PubMed ID: 24253142
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
Mimeault M; Batra SK
J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
[TBL] [Abstract][Full Text] [Related]
4. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
[TBL] [Abstract][Full Text] [Related]
5. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
6. CD133: holy of grail of neuro-oncology or promiscuous red-herring?
Donovan LK; Pilkington GJ
Cell Prolif; 2012 Dec; 45(6):527-37. PubMed ID: 23106300
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
Schöning JP; Monteiro M; Gu W
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease in cancer therapy--Small things make all the difference.
Blatter S; Rottenberg S
Drug Resist Updat; 2015; 21-22():1-10. PubMed ID: 26307504
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disseminated cancer cell dormancy: an awakening field.
Sosa MS; Bragado P; Aguirre-Ghiso JA
Nat Rev Cancer; 2014 Sep; 14(9):611-22. PubMed ID: 25118602
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications.
Shi R; Liao C; Zhang Q
Cells; 2021 Mar; 10(3):. PubMed ID: 33808542
[TBL] [Abstract][Full Text] [Related]
12. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.
Lin Q; Yun Z
Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454
[TBL] [Abstract][Full Text] [Related]
13. Toward Minimal Residual Disease-Directed Therapy in Melanoma.
Rambow F; Rogiers A; Marin-Bejar O; Aibar S; Femel J; Dewaele M; Karras P; Brown D; Chang YH; Debiec-Rychter M; Adriaens C; Radaelli E; Wolter P; Bechter O; Dummer R; Levesque M; Piris A; Frederick DT; Boland G; Flaherty KT; van den Oord J; Voet T; Aerts S; Lund AW; Marine JC
Cell; 2018 Aug; 174(4):843-855.e19. PubMed ID: 30017245
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia.
D'Uva G; Bertoni S; Lauriola M; De Carolis S; Pacilli A; D'Anello L; Santini D; Taffurelli M; Ceccarelli C; Yarden Y; Montanaro L; Bonafé M; Storci G
PLoS One; 2013; 8(11):e80742. PubMed ID: 24260469
[TBL] [Abstract][Full Text] [Related]
15. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-mediated biological control.
Cassavaugh J; Lounsbury KM
J Cell Biochem; 2011 Mar; 112(3):735-44. PubMed ID: 21328446
[TBL] [Abstract][Full Text] [Related]
17. The secretome in cancer progression.
Paltridge JL; Belle L; Khew-Goodall Y
Biochim Biophys Acta; 2013 Nov; 1834(11):2233-41. PubMed ID: 23542208
[TBL] [Abstract][Full Text] [Related]
18. Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer.
Chen J; Zhang M; Ma Z; Yuan D; Zhu J; Tuo B; Li T; Liu X
Cell Oncol (Dordr); 2021 Aug; 44(4):739-749. PubMed ID: 33856653
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated cancer stem cell resistance and targeted therapy.
Sun X; Lv X; Yan Y; Zhao Y; Ma R; He M; Wei M
Biomed Pharmacother; 2020 Oct; 130():110623. PubMed ID: 32791395
[TBL] [Abstract][Full Text] [Related]
20. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
